Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554855-26-001058
Filing Date
2026-05-15
Accepted
2026-05-15 08:11:31
Documents
68
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sxtp-20260331.htm   iXBRL 10-Q 1425052
7 EXHIBIT 31.1 ex311_1.htm EX-31.1 12294
8 EXHIBIT 31.2 ex312_2.htm EX-31.2 12070
9 EXHIBIT 32.1 ex321_3.htm EX-32.1 5643
10 EXHIBIT 32.2 ex322_4.htm EX-32.2 5468
  Complete submission text file 0001554855-26-001058.txt   7865968

Data Files

Seq Description Document Type Size
2 DEFINITION sxtp-20260331_def.xml EX-101.DEF 340463
3 PRESENTATION sxtp-20260331_pre.xml EX-101.PRE 502147
4 CALCULATION sxtp-20260331_cal.xml EX-101.CAL 82150
5 LABEL sxtp-20260331_lab.xml EX-101.LAB 952023
6 SCHEMA sxtp-20260331.xsd EX-101.SCH 68349
72 EXTRACTED XBRL INSTANCE DOCUMENT sxtp-20260331_htm.xml XML 1032163
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

EIN.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41719 | Film No.: 26982450
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)